In a report, the regulator sharply criticized pharmacy benefit managers, a turnaround from its longstanding tolerance of their practices. Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Health Insurance and Managed Care, Drugstores, Antitrust Laws and Competition Issues, Regulation and Deregulation of Industry, pharmacy benefit managers, United States Politics and Government, CIGNA Corporation, CVS Caremark Corporation, Express Scripts Inc, Federal Trade Commission, UnitedHealth Group Inc, Khan, Lina NYT > Health
In a report, the regulator sharply criticized pharmacy benefit managers, a turnaround from its longstanding tolerance of their practices.
